描述对乌干达 25-49 岁感染人类免疫缺陷病毒 (HIV) 的女性扩大宫颈癌筛查和治疗的情况，并分析计划数据。卫生部在 2 年内以现有的艾滋病毒诊所为目标从 2020 年 10 月起扩大宫颈癌筛查服务。在准备过程中，我们培训了卫生工作者，通过人乳头瘤病毒 (HPV) 检测和/或醋酸目视检查来评估前往艾滋病毒诊所就诊的妇女的筛查资格。诊所工作人员对患有宫颈癌前病变的女性进行热凝治疗，或将疑似癌症的女性转诊至外部服务机构。我们分析了每 6 个月报告的提供筛查的诊所数量、筛查接受率、阳性诊断数量和接受治疗的女性人数的数据。提供宫颈癌筛查服务的 HIV 诊所数量从该计划启动前的 11 家增加，到 1571。在该计划期间，筛查率从目标的 5.0% (6506/130 293) 增加到 107.3% (151 872/141 527)。总体而言，阳性诊断的累积比例为 5.9% (23 970/407 323)，但与提供 HPV 检测的诊所相比，仅提供目视检查的筛查要低得多。尽管接受治疗的女性比例如果呈阳性则从 12.8% (53/413) 增加到 84.3% (8087/9592)，但尚未达到世界卫生组织 90% 的目标。我们证明了显着的增加，可能会被其他国家复制，在筛查和治疗方面。通过扩大 HPV 检测和癌前病变的当日治疗，可以进一步改善这些增长。(c) 2024 作者；被许可人世界卫生组织。

To describe the scale-up of cervical cancer screening and treatment for women living with human immunodeficiency virus (HIV), aged 25-49 years in Uganda, and to analyse the programme data.The health ministry targeted existing HIV clinics in a 2-year scale-up of cervical cancer screening services from October 2020. In preparation, we trained health workers to assess women attending HIV clinics for screening eligibility, provided either by human papillomavirus (HPV) testing and/or visual inspection with acetic acid. Clinic staff treated women with precancerous cervical lesions with thermocoagulation or referred women with suspected cancer to external services. We analysed data reported every 6 months for the number of clinics offering screening, screening uptake, the number of positive diagnoses and the number of women who received treatment.The number of HIV clinics offering cervical cancer screening services increased from 11, before the programme launch, to 1571. During the programme, screening uptake increased from 5.0% (6506/130 293) to 107.3% (151 872/141 527) of targets. The cumulative proportion of positive diagnoses was 5.9% (23 970/407 323) overall, but was much lower for screening offering visual inspection only compared with clinics offering HPV testing. Although the proportion of women receiving treatment if positive increased from 12.8% (53/413) to 84.3% (8087/9592), the World Health Organization target of 90% was not reached.We demonstrated marked increases, potentially replicable by other countries, in screening and treatment. These increases could be improved further by expanding HPV testing and same-day treatment of precancerous lesions.(c) 2024 The authors; licensee World Health Organization.